Press Releases

Jun 14, 2004 HEMISPHERX BIOPHARMA LAUNCHES MULTIPLE SCLEROSIS SALVAGE PROGRAM WITH NATURAL INTERFERONS

Jun 01, 2004 HEMISPHERX BIOPHARMA RECEIVES APPROVAL FOR WEST NILE VIRUS PROTOCOL WITH ALFERON N TREATMENT

May 17, 2004 HEMISPHERX FILES EXPANDED U.S. PATENT APPLICATION FOR TREATING SARS AND EMERGING VIRUSES

May 14, 2004 HEMISPHERX BIOPHARMA FIRST QUARTER 2004 EARNINGS ANNOUNCED

May 10, 2004 HEMISPHERX BIOPHARMA LAUNCHES NEW HIV CLINICAL PROGRAM IN AFRICA WITH COST EFFECTIVE ANTIVIRAL DELIVERY

May 03, 2004 HEMISPHERX BIOPHARMA ANNOUNCES PHASE 3 CHRONIC FATIGUE SYNDROME TRIAL MEETS PRIMARY ENDPOINT

Apr 30, 2004 Hemispherx Biopharma Accelerates Release Date on Phase 3 Data for Ampligen in CFS

Apr 20, 2004 HEMISPHERX BIOPHARMA CEO TO PRESENT AT WHITE MOUNTAIN CAPITAL BIOTECHNOLOGY CONFERENCE

Apr 19, 2004 HEMISPHERX BIOPHARMA REPORTS PUBLICATION SHOWING SUPERIOR ACTIVITY OF ALFERON AGAINST SARS

Apr 13, 2004 Hemispherx Biopharma to Present First Phase 3 Data on Ampligen in Chronic Fatigue Syndrome at the 17th International Conference on Antiviral Research

62 63 64 65 66 67 68 69 70 71 72

<< < > >>